Dexamethasone news

All news on Dexamethasone (also known as Decadron and Dexasone): plants, production capacities, investments and involved companies.

11 February 2026

Merck's KEYTRUDA and KEYTRUDA QLEX Approved for PD-L1+ Platinum-Resistant Ovarian Cancer

FDA approves KEYTRUDA regimens for platinum-resistant ovarian cancer, showing reduced disease progression and death risk in trials.

Who will be producing Dexamethasone in the future?

Find out with chemXplore Analytics